Also known as: Osteogenic protein-1 (OP-1)
Ember Therapeutics (Licensor)Knight Therapeutics (Licensee)
Ember grants Knight exclusive rights to commercialize Ember's bone morphogenetic protein 7 (BMP7; OP-1) pipeline in Canada, Israel, Russia and sub-Saharan Africa
Ember Therapeutics (Other)Mariel (Other)
Obesity and diabetes company Ember and Mariel merging to form Ember Therapeutics Inc.
Set Email Alert